Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.

Ann Lab Med 2012 Nov 17;32(6):426-8. Epub 2012 Oct 17.

Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15 tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system (bioMérieux, France). Overall susceptibility rates were 98.1%, 95.9%, 99.1%, and 97.3% for amphotericin B, fluconazole, voriconazole, and flucytosine, respectively. The results show that the rates of resistance to 4 antifungal drugs remain low among Candida bloodstream isolates in Korea.

Download full-text PDF

Source
http://dx.doi.org/10.3343/alm.2012.32.6.426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486937PMC
November 2012
5 Reads

Publication Analysis

Top Keywords

candida bloodstream
12
bloodstream isolates
12
antifungal susceptibility
8
fluconazole voriconazole
8
amphotericin fluconazole
8
voriconazole flucytosine
8
hospitals korea
8
tertiary hospitals
8
susceptibility system
4
yeast susceptibility
4
drugs remain
4
collected tertiary
4
isolates collected
4
korea determined
4
determined vitek-2
4
antifungal drugs
4
vitek-2 yeast
4
france susceptibility
4
981% 959%
4
959% 991%
4

Similar Publications